Analysts Set Dolby Laboratories (NYSE:DLB) Price Target at $92.00

Shares of Dolby Laboratories (NYSE:DLBGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the six analysts that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $92.00.

DLB has been the subject of a number of recent analyst reports. Rosenblatt Securities cut their price target on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a report on Wednesday, November 19th. Barrington Research cut their price objective on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday. Robert W. Baird assumed coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 price target for the company. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday.

Read Our Latest Report on Dolby Laboratories

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, SVP John D. Couling sold 7,273 shares of Dolby Laboratories stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $68.75, for a total value of $500,018.75. Following the completion of the transaction, the senior vice president directly owned 108,065 shares of the company’s stock, valued at $7,429,468.75. The trade was a 6.31% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin J. Yeaman sold 36,699 shares of the stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $66.91, for a total transaction of $2,455,530.09. Following the sale, the chief executive officer directly owned 114,725 shares in the company, valued at $7,676,249.75. This represents a 24.24% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 162,120 shares of company stock valued at $10,906,559. Insiders own 38.39% of the company’s stock.

Institutional Investors Weigh In On Dolby Laboratories

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Cetera Investment Advisers lifted its holdings in shares of Dolby Laboratories by 6.1% during the first quarter. Cetera Investment Advisers now owns 4,883 shares of the electronics maker’s stock worth $392,000 after purchasing an additional 282 shares during the period. US Bancorp DE raised its holdings in Dolby Laboratories by 18.6% during the first quarter. US Bancorp DE now owns 1,444 shares of the electronics maker’s stock worth $116,000 after purchasing an additional 226 shares in the last quarter. Nuveen LLC acquired a new position in Dolby Laboratories during the 1st quarter worth approximately $16,890,000. Resona Asset Management Co. Ltd. raised its stake in shares of Dolby Laboratories by 2.2% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 10,911 shares of the electronics maker’s stock worth $876,000 after buying an additional 235 shares in the last quarter. Finally, Russell Investments Group Ltd. grew its holdings in Dolby Laboratories by 53.7% during the first quarter. Russell Investments Group Ltd. now owns 62,918 shares of the electronics maker’s stock worth $5,051,000 after acquiring an additional 21,994 shares during the period. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Stock Performance

Shares of Dolby Laboratories stock opened at $66.26 on Monday. The business’s 50 day moving average price is $66.78 and its 200 day moving average price is $71.16. The company has a market cap of $6.33 billion, a price-to-earnings ratio of 25.19 and a beta of 0.89. Dolby Laboratories has a one year low of $64.02 and a one year high of $89.66.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, topping the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. During the same quarter in the previous year, the firm earned $0.61 EPS. The company’s quarterly revenue was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, analysts predict that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were issued a $0.36 dividend. The ex-dividend date was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio (DPR) is presently 54.75%.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Analyst Recommendations for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.